Introduction
An estimated 125 million pregnancies continue to occur every year in the countries with ongoing malaria transmission. More than half of these malaria-exposed pregnancies occur in areas with unstable Plasmodium falciparum (P. falciparum) transmission where the greatest risk of malaria infection in pregnancy is concentrated in sub-Saharan Africa (Dellicour et al. 2010; Epidemiology of Malaria During Pregnancy: Burden and Impact of P. falciparum Malaria on Maternal and Infant Health). Pregnant women are also at risk with Plasmodium vivax (P. vivax) malaria, though, in contrast, the risk of acquiring the infection in these areas appears to be lower (see Epidemiology of Malaria During Pregnancy: Burden and Impact of P. vivax Malaria on Maternal and Infant Health).
The impact of P. falciparuminfection in pregnancy has been well documented in sub-Saharan Africa where it is widely recognized that pregnant...
This is a preview of subscription content, log in via an institution to check access.
References
Bardaji A, Sigauque B, Sanz S, Maixenchs M, Ordi J, et al. Impact of malaria at the end of pregnancy on infant mortality and morbidity. J Infect Dis. 2011;203:691–9.
Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010;7:e1000221.
Desai M, ter Kuile FO, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7(2):93–104.
Gonzalez R, Desai M, Macete E, Ouma P, Kakolwa MA, Abdulla S, Aponte JJ, Bulo H, Kabanywanyi AM, Katana A, et al. Intermittent preventive treatment of malaria in pregnancy with Mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial. PLoS Med. 2014;11:e1001735.
Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, Duffy PE. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci USA. 2009;106(22):9027–32.
Hill J, Kazembe P. Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges. Trop Med Int Health: TM & IH. 2006;11:409–18.
Hill J, Hoyt J, van Eijk AM, D’Mello-Guyett L, Ter Kuile FO, Steketee R, Smith H, Webster J. Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2013;10:e1001488.
Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, Vanden Eng J, Owino SO, Lal AA, Omosun YO, Otieno K, Desai M, Ter Kuile FO, Nahlen B, Moore J, Hamel MJ, Ouma P, Slutsker L, Shi YP. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malar J. 2012;11(1):134.
Menendez C, D’Alessandro U, ter Kuile FO. Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis. 2007;7:126–35.
Menendez C, Ferenchick E, Roman E, Bardají A, Mangiaterra V. Malaria in pregnancy: challenges for control and the need for urgent action. Lancet Glob Health. 2015;3(8):e433–4.
Minzi OM, Moshi MJ, Hipolite D, Massele AY, Tomson G, Ericsson O, Gustafsson LL. Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania. J Clin Pharm Ther. 2003;28:117–22.
Mockenhaupt FP, Bedu-Addo G, Eggelte TA, Hommerich L, Holmberg V, von Oertzen C, Bienzle U. Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana. J Infect Dis. 2008;198(10):1545–9.
Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, Hkirijaroen L, Looareesuwan S, White NJ. Effects of Plasmodium vivax malaria in pregnancy. Lancet. 1999;354:546–9.
Onoka CA, Onwujekwe OE, Hanson K, Uzochukwu BS. Sub-optimal delivery of intermittent preventive treatment for malaria in pregnancy in Nigeria: influence of provider factors. Malar J. 2012;11:317.
Rodriguez-Morales AJ, Sanchez E, Vargas M, Piccolo C, Colina R, Arria M, Franco-Paredes C. Pregnancy outcomes associated with Plasmodium vivax malaria in northeastern Venezuela. Am J Trop Med Hyg. 2006;74(5):755–7.
Roman E, et al. Moving malaria in pregnancy programs from neglect to priority: experience from Malawi, Senegal, and Zambia. Glob Health Sci Pract. 2014;2(1):55–71. doi:10.9745/GHSP-D-13-00136. First published online January 27, 2014.
Rwanda-National-Institute-Statistics, Ministry of Finance and Economic Planning, Ministry of Health-Kigali-Rwanda, MEASURE DHS-ICF International C-M-U. Rwanda DHS, 2010. The DHS Program 2010, Available at http://dhsprogram.com/publications/publication-FR259-DHS-Final-Reports.cfm. [Accessed Oct 2014].
Sevene E, Gonzalez R, Menendez C. Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy. Expert Opin Pharmacother. 2010;11:1277–93.
Sicuri E, Bardaji A, Nhampossa T, et al. Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique. PLoS One. 2010;5:e13407.
Tanzania-National-Bureau of Statistics, Tanzania and ICF Macro-Calverton-Maryland-USA: Tanzania DHS, 2010. The DHS Program 2010. Available at http://dhsprogram.com/publications/publication-FR243-DHS-Final-Reports.cfm. [Accessed Oct 2014].
Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, Ter Kuile FO, Meshnick SR, Rogerson SJ. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Clin Infect Dis. 2012;55:42–50.
ter Kuile FO, Parise ME, Verhoeff FH, Udhayakumar V, Newman RD, van Eijk AM, Rogerson SJ, Steketee RW. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg. 2004;71:41–54.
van Eijk AM, Hill J, Alegana VA, Kirui V, Gething PW, ter Kuile FO, Snow RW. Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data. Lancet Infect Dis. 2011;11:190–207.
Wallon M, Roman E, Brieger W, Rawlins B. A malaria in pregnancy case study: Zambia’s successes and remaining challenges for malaria in pregnancy programming. President’s Malaria Initiative and Maternal and Child Health Integrated Program (MCHIP) 2010, Available at http://www.mchip.net/files/MCHIPZambiaCaseStudy.pdf [Accessed Oct 2014].
WHO. Guidelines for the treatment of malaria. Second edition. WHO; 2010, ISBN 9789241547925
WHO. Intermittent preventive treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP). Updated WHO Policy Recommendation. WHO; 2012.
WHO. The African summit on roll back malaria, Abuja, 25 April 2000 (WHO/CDS/RBM/200017) 2000.
WHO. WHO expert consultation on cotrimoxazole prophylaxis in HIV infection. Geneva: WHO; 2006.
WHO. WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). WHO; 2014, WHO/HTM/GMP/2014.4.
WHO. World malaria report 2013. WHO; 2013.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this entry
Cite this entry
Menéndez, C., Ferenchick, E., Bardají, A., Mangiaterra, V. (2015). Current Challenges and Research Gaps. In: Hommel, M., Kremsner, P. (eds) Encyclopedia of Malaria. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8757-9_73-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8757-9_73-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-8757-9
eBook Packages: Springer Reference MedicineReference Module Medicine